A recent study reveals that weight-loss medications such as Ozempic may reduce the risk of obesity-related cancers, including colorectal and breast cancer. Experts emphasise the importance of further ...

Despite the many people praising medications like Ozempic, some are unaware of the potential issues that can arise from ...

Popular GLP-1 weight-loss drugs like Ozempic and Zepbound can help reduce a woman's risk for as many as 14 cancers associated ...

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Illustration of a semaglutide peptide (blue) bound to its target glucagon-like peptide-1 (GLP-1, light pink).

After a blood test during her annual physical uncovered low hemoglobin levels, she underwent numerous tests and learned she had Stage 3 colorectal cancer. “They found a softball- and golf ball ...

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

These meds go by the brand names Ozempic, Wegovy and Mounjaro ... Keeping a healthy weight as an adult decreases cardiometabolic risk factors and may extend lifespan. Semaglutide is a powerful tool ...

In today’s increasingly sedentary world, sitting too much is raising the risk of many serious diseases, including cancer. But could something as simple as walking offer real protection? It turns out ...

Ozempic and Wegovy, medications that have become increasingly popular this year due to their weight loss effects, were both tested on a monkey species listed as endangered, according to a National ...